0.500
-0.01 (-1.94%)
| Penutupan Terdahulu | 0.510 |
| Buka | 0.533 |
| Jumlah Dagangan | 1,984 |
| Purata Dagangan (3B) | 38,980 |
| Modal Pasaran | 13,981,988 |
| Harga / Jualan (P/S) | 0.820 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 14 Nov 2025 |
| Margin Keuntungan | -61.07% |
| Margin Operasi (TTM) | -23.10% |
| EPS Cair (TTM) | -0.550 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 16.50% |
| Nisbah Semasa (MRQ) | 0.220 |
| Aliran Tunai Operasi (OCF TTM) | -2.38 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -3.03 M |
| Pulangan Atas Aset (ROA TTM) | -26.43% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Biotricity Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -1.67 |
|
Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed; Bioheart, which is a personal heart monitor; Biokit, and Biocare health. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 39.37% |
| % Dimiliki oleh Institusi | 2.51% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Strengthening Families & Communities, Llc | 30 Sep 2025 | 48,263 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |